Exchange Traded Concepts’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-64,409
| Closed | -$82.1K | – | 1416 |
|
|
2024
Q4 | $82.1K | Hold |
64,409
| – | – | ﹤0.01% | 1173 |
|
|
2024
Q3 | $133K | Buy |
64,409
+15,682
| +32% | +$32.5K | ﹤0.01% | 1097 |
|
|
2024
Q2 | $186K | Sell |
48,727
-15,160
| -24% | -$57.8K | ﹤0.01% | 884 |
|
|
2024
Q1 | $303K | Buy |
63,887
+19,800
| +45% | +$93.9K | 0.01% | 791 |
|
|
2023
Q4 | $188K | Buy |
44,087
+11,180
| +34% | +$47.7K | 0.01% | 794 |
|
|
2023
Q3 | $102K | Buy |
32,907
+7,479
| +29% | +$23.1K | ﹤0.01% | 886 |
|
|
2023
Q2 | $114K | Buy |
+25,428
| New | +$114K | ﹤0.01% | 921 |
|